Blu – Pagina 146 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Febbraio 23, 2023 Alice Lione

Fracture risks associated with sodium-glucose cotransporter 2 inhibitors in type 2 diabetes patients across eGFR and albuminuria categories: a population-based study in Hong Kong

Lui DTW, Wu T, Tang EHM, et al.
Diabetes Res Clin Pract. 2023;110576.

Leggi

Febbraio 23, 2023 Alice Lione

Effects of semaglutide on albuminuria and kidney function in people with overweight or obesity with or without type 2 diabetes: exploratory analysis from the STEP 1, 2, and 3 trials

Heerspink HJL, Apperloo E, Davies M, et al.
Diabetes Care. 2023;dc221889.

Leggi

Febbraio 23, 2023 Alice Lione

Impact of changes in diabetes screening guidelines on testing eligibility and potential yield among adults without diagnosed diabetes in the United States

Ali MK, Imperatore G, Benoit SR, et al.
Diabetes Res Clin Pract. 2023;197:110572.

Leggi

Febbraio 17, 2023 Alice Lione

Extended use of an open-source automated insulin delivery system in children and adults with type 1 diabetes: The 24-week continuation phase following the CREATE randomized controlled trial

Burnside M, Lewis D, Crocket H, et al.
Diabetes Technol Ther. Pub. online 10 Feb 2023.

Leggi

Febbraio 17, 2023 Alice Lione

Sulfonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: a population‐based cohort study

Islam N, Reynier P, Douros A, et al.
Diabetes Obes Metab. Pub. online 1 Feb 2023.

Leggi

Febbraio 17, 2023 Alice Lione

Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial

Gullaksen S, Vernstrøm L, Sørensen SS, et al.
Diabetologia. Pub. online 6 Feb 2023.

Leggi

Febbraio 13, 2023 Alice Lione

Pregnancy after bariatric surgery

Fisher SA, Stetson BT, Kominiarek MA
JAMA. Pub. online 10 Feb 2023.

Leggi

Febbraio 13, 2023 Alice Lione

Integrated safety and efficacy analysis of dasiglucagon for treatment of severe hypoglycaemia in individuals with type 1 diabetes

Heller S, Battelino T, Bailey TS, et al.
Diabetes Obes Metab.Pub. online 24 Jan 2023.

Leggi

Febbraio 13, 2023 Alice Lione

Meta‐analysis of head‐to‐head clinical trials comparing incretin‐based glucose‐lowering medications and basal insulin – an update including recently developed GLP‐1 receptor agonists and the GIP/GLP‐1 receptor co‐agonist tirzepatide

Nauck MA, Mirna AEA, Quast DR
Diabetes Obes Metab. Pub. online 26 Jan 2023.

Leggi

Febbraio 13, 2023 Alice Lione

Four-year visual outcomes in the protocol W randomized trial of intravitreous aflibercept for prevention of vision-threatening complications of diabetic retinopathy

Maturi RK, Glassman AR, Josic K, et al.
JAMA. 2023;329(5):376-385.

Leggi